Teoriya i praktika fizicheskoy kultury №6 2017, pp.51-53

A.D. Zolotareva¹
PhD O.S. Glotov^{1, 2}
PhD M.V. Aseev^{1, 2}
E.S. Vashukova¹
Dr.Med., Professor S.G. Shcherbak^{1, 2
1}St. Petersburg State University, St. Petersburg
²City Hospital No. 40, St. Petersburg

Hypoxic tolerance of mountaineers provides an interesting subject for in vivo studies of hypoxic adaptation mechanisms activated by a shortage of oxygen. We have studies rs2070744, rs1799983 SNP-markers in NOS3 (eNOS) gene by Real-Time Polymerase Chain Reaction (PCR) method in 80 mountaineers who at least once in a lifetime reached the altitudes of above 3000 m versus the general population group. For the purposes of the statistical data analysis, we grouped the sampled mountaineers depending on the reportedly reached altitudes and diagnosed/ non-diagnosed acute altitude sickness (AAS).
No significant intergroup data differences were found for the frequencies of alleles in rs1799983 and rs2070744 positions in the altitude-specific groups (under 4500 m, 4500-6000 m and above 6000 m) versus the general population group. Furthermore, no statistically significant correlations were found in the SNP-markers in NOS3 gene versus the maximal altitudes reported by the subjects. The AAS/ non-AAS group data showed correlation of the thiamine in rs2070744 position in NOS3 gene versus the AAS degree. The study data give reasons to assume that the T-allele carriers are prone to AAS with a probability rate of 61%; and the data gives us the reasons to offer a hypothesis that the T-allele in rs2070744 position may be suppressing the nitrogen oxide synthetase effects on the vessels relaxation mechanism thereby increasing the risks of AAS.

Keywords: gene polymorphism, acute altitude sickness (AAS), mountaineering, allele frequency analysis, hypoxia.

References

1. Glotov O.S., Glotov A.S., Pakin V.S., Baranov V.S. Monitoring zdorovya cheloveka – vozmozhnosti sovremennoy genetiki [Monitoring of human health - opportunities of modern genetics]. Vestnik Sankt-Peterburgskogo un-ta, 2013, vol. 3, no. 2, pp. 95 107.
2. Kravchenko N.A., Yarmysh N.V. Regulyatsiya ekspressii endotelialnoy NO-sintetazy i disfunktsiya sosudistogo endoteliya pri serdechno-sosudistoy patologii [Regulation of expression of endothelial NOS and dysfunction of vascular endothelium in cardiovascular pathology]. Tsitologiya i genetika, 2008, no. 4, pp.69-80.
3. Rebrova O.Y. Statisticheskiy analiz meditsinskikh dannykh. Primenenie paketa prikladnykh programm STATISTICA [Statistical analysis of medical data. Application of STATISTICA package]. Moscow: MediaSfera publ., 2002.
4. Augeri A.L. et al. The endothelial nitric oxide synthase −786 T>C polymorphism and the exercise-induced blood pressure and nitric oxide responses among men with elevated blood pressure. Atherosclerosis. 2009, vol. 204, pp. 28–34.
5. Harvey V. Lankford, MD Extreme Altitude: Words From on High. Wilderness & environmental medicine. 2014, pp. 346–351.
6. Miyahara K., Kawamoto T., Sase K., et al. Cloning and structural characterization of the human endothelial nitric-oxide-synthase gene. Eur. J Biochem. 1994, vol. 223(3), pp. 719-726.
7. Montgomery H.E., Marshall R., Hemingway H., Myerson S., Clarkson P., Dollery C., Hayward M., Holliman D.E., Jubb M., World M. et al. Human gene for physical performance. Nature. 1998, vol. 393. pp. 221-2.
8. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor: Cold Spring Harbor Lab. Press, 1989, 398 p.
9. Wang GL et al. Hypoxia- inducible factor- 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proceedings of the National Academy of Sciences of the United States of America. 1995, vol. 92, pp. 5510-5514.
10. Yang F. et al. Association of endothelin-1 gene polymorphisms with the clinical phenotype in primary nephrotic syndrome of children. Life Sci. 2012, vol. 5.